A beginner’s guide to immunotherapy


Please be aware that this will be a virtual event. Details to be confirmed.


Description: A half-day course repeated morning and afternoon describing the theory behind the new immunotherapy treatments for cancer such as checkpoint inhibitors (ipilimumab, pembrolizumab, nivolumab, atezolizumab, durvalumab), adoptive cell therapy (CAR T cell therapy, infiltrating T cells), and vaccine-based treatments (peptide and DNA vaccines, oncolytic viruses, dendritic cell vaccines).
Level: Intermediate
Cost: £100
Audience: Ideal for anyone with an A level or equivalent understanding of cell biology and genetics and who works with cancer patients, data or treatments.
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
View an outline of the programme